C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2006
12/28/2006	US20060292669 Mammalian prickle gene
12/28/2006	US20060292667 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone
12/28/2006	US20060292665 Glutaryl amidases and their uses
12/28/2006	US20060292655 2-O sulfatase compositions and methods of analyzing therewith
12/28/2006	US20060292651 Protein labelling with oº-alkylguanine-dna alkyltrnsferase
12/28/2006	US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases
12/28/2006	US20060292643 Recognition molecules for the treatment and detection of tumours
12/28/2006	US20060292638 Sequence #115 as a target for identifying weight modulating compounds
12/28/2006	US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase
12/28/2006	US20060292634 Structure for presenting desired peptide sequences
12/28/2006	US20060292633 Method for modulating process mediated by farnesoid activated receptors
12/28/2006	US20060292629 Chimeric polypeptides and their use
12/28/2006	US20060292627 PB39, a gene dysregulated in prostate cancer, and uses thereof
12/28/2006	US20060292622 determining the presence of or predisposition to early-onset spinocerebellar ataxia with ocular motor aprataxia and hypoalbuminemia in a human; neurodegenerative disease
12/28/2006	US20060292621 Randomized libraries of zinc finger proteins
12/28/2006	US20060292614 Methods of gene expression monitoring
12/28/2006	US20060292608 Using fluorescent profiles to reveal variation in genic copy number in cells; diagnosing cell proliferative disorders
12/28/2006	US20060292606 Using g-protein coupled receptor to identify modulators for prevention and treatment of schizophrenia and related psychoses
12/28/2006	US20060292603 Method for selecting a chemical entity from a tagged library
12/28/2006	US20060292599 Methods to detect lineage-specific cells
12/28/2006	US20060292598 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy
12/28/2006	US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
12/28/2006	US20060292588 Assay systems, kits and methods for detecting microorganisms
12/28/2006	US20060292582 Methods for nucleic acid manipulation
12/28/2006	US20060292580 Cleavage of nucleic acids
12/28/2006	US20060292579 Methods of enzymatic discrimination enhancement and surface bound double-stranded DNA
12/28/2006	US20060292578 Nucleotide sequences coding thermus filiformis heat resistant transferase with reduced exonuclease activity; for use in DNA sequencing, nucleic acid amplification, cDNA and nucleic synthesis
12/28/2006	US20060292573 Human orthologues of WART
12/28/2006	US20060292566 Method for optimising gene expressing using synonymous codon optimisation
12/28/2006	US20060292563 Methods of diagnosing & treating diabetes and insulin resistance
12/28/2006	US20060292561 Dna enzymes
12/28/2006	US20060292560 Transcription factor target gene discovery
12/28/2006	US20060292554 Major coat protein variants for C-terminal and bi-terminal display
12/28/2006	US20060292551 cationic peptides useful in the treatment of dermatitis and viral infections; for topical administration
12/28/2006	US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception
12/28/2006	US20060292546 Herg channel-expressing cell
12/28/2006	US20060292183 forming oil in water emulsions containing drugs by heating nanostructure particle size matrices, surfactants and drugs, then cooling while stirring
12/28/2006	US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide
12/28/2006	US20060292178 Proteins encoded by the severe acute respiratory syndrome (SARS) coronavirus and a role in apoptosis
12/28/2006	US20060292177 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/28/2006	US20060292175 Chimeric alphavirus replicon particles
12/28/2006	US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
12/28/2006	US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
12/28/2006	US20060292160 Specifically reacts with HIV-infected cells and induces apoptosis to the infected cells to lead the cells to destruction; immunoglobulins
12/28/2006	US20060292143 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
12/28/2006	US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin
12/28/2006	US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence
12/28/2006	US20060292130 2-O sulfatase nucleic acid compositions
12/28/2006	US20060292123 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
12/28/2006	US20060292122 Adenoviral vectors for treating diseases
12/28/2006	US20060292121 Retroviral vectors including modified envelope escort protein
12/28/2006	US20060292120 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
12/28/2006	US20060292118 Hollow nanoparticles of protein and drug using the same
12/28/2006	US20060292117 Improved rAAv vectors
12/28/2006	US20060292116 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
12/28/2006	DE19931819B4 11-Arachidonat-Lipoxygenase-Mutante Arachidonate 11-lipoxygenase mutant
12/28/2006	DE102005029721A1 Construction of functionalized plasmids with clonable and spontaneously self-organizing permanent structures for immobilization/hybridization on anchor plasmids, comprises construction of oligonucleotides and a partial palindromic insert
12/28/2006	DE102005027139A1 Neue Cystein-verarmte Hydrophobinfusionsproteine, deren Herstellung und Verwendung New cysteine-depleted hydrophobin, their preparation and use
12/28/2006	DE102004032888B4 Rekombinante ScV-Partikel, ihre kodierenden Nukleinsäuren und ihre Verwendungen Recombinant SCV particle, its encoding nucleic acids and their uses
12/28/2006	CA2850323A1 Methods and compositions involving mirna and mirna inhibitor molecules
12/28/2006	CA2680945A1 Anti-pdgfralpha antibodies
12/28/2006	CA2620946A1 Amniotic cells and methods for use thereof
12/28/2006	CA2613480A1 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
12/28/2006	CA2613257A1 A novel biological substance nesfatin and its related substances and uses thereof
12/28/2006	CA2613163A1 Selection of phosphatase-coding nucleic acid molecules
12/28/2006	CA2613160A1 Methods for altering the reactivity of plant cell walls
12/28/2006	CA2612859A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy
12/28/2006	CA2612458A1 Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry
12/28/2006	CA2612445A1 Improved methods for the production of stably transformed, fertile zea mays plants
12/28/2006	CA2612389A1 Genemap of the human genes associated with longevity
12/28/2006	CA2612374A1 Methods for treating demyelination disorders
12/28/2006	CA2612302A1 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis
12/28/2006	CA2612252A1 Methods and compositions for gene silencing
12/28/2006	CA2612240A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae
12/28/2006	CA2611924A1 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
12/28/2006	CA2611513A1 Improved amino acid and metabolite biosynthesis
12/28/2006	CA2609077A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth
12/28/2006	CA2608278A1 Immunogenic compositions for chlamydia trachomatis
12/28/2006	CA2607859A1 Murine stem cells and applications thereof
12/28/2006	CA2587189A1 Methods and compositions involving mirna and mirna inhibitor molecules
12/27/2006	EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof
12/27/2006	EP1736554A2 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
12/27/2006	EP1736551A1 Method of producing liquid cell extract for cell-free protein synthesis
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736546A1 Using nonhuman animal model, method of measuring transcription activity, method of measuring cell quantity and method of measuring tumor volume
12/27/2006	EP1736545A2 Soluble zcytor 11 cytokine receptors
12/27/2006	EP1736544A1 Gm1 PROMOTER AND USE THEREOF
12/27/2006	EP1736543A1 Method of detecting and quantifying wheat endogenous dna sequence
12/27/2006	EP1736542A1 Solvent for dissolving nucleic acid, nucleic acid-containing solution and method of preserving nucleic acid
12/27/2006	EP1736541A1 Novel galectin 9 modification protein and use thereof
12/27/2006	EP1736540A1 Process for producing dipeptides
12/27/2006	EP1736484A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
12/27/2006	EP1736482A1 Recombinant trimeric 4-1BBL
12/27/2006	EP1736479A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
12/27/2006	EP1736172A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
12/27/2006	EP1736171A1 Antiobesity drug
12/27/2006	EP1736170A2 Agent for treating allergic or hypersensitivity condition
12/27/2006	EP1736168A1 Protease inhibitor and preventives or remedies for diseases
12/27/2006	EP1736163A1 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
12/27/2006	EP1736162A1 Remedy for prion disease and method of producing the same

1 ... 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 ... 4023